Status:

ACTIVE_NOT_RECRUITING

Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy

Lead Sponsor:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborating Sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)

National Institutes of Health Clinical Center (CC)

Conditions:

Genetic Disorder

Eligibility:

All Genders

18-99 years

Brief Summary

Background: \- Some kinds of muscular dystrophy affect the skeletal muscle membrane. In these conditions, the muscle membrane is more fragile. This affects how the muscles contract and relax, which c...

Detailed Description

Objectives: the aim of this protocol is to identify biomarker and clinical correlates of changes in the barrier function of skeletal muscle membrane (i.e. cell membrane permeability) before and after ...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Aged 18 or older
  • Have a confirmed genetic diagnosis of one of the FSMDs or have a clinical phenotype consistent with one of the FSMDs
  • Be able to travel to the NIH Clinical Center at the NIH for studies
  • Able to commit to multiple 5 day stays at the NIH Clinical Center
  • Established primary care physician
  • Ambulant: able to walk 10 meters or 33 feet without walking aids or orthotics
  • EXCLUSION CRITERIA:
  • Fail to meet the above inclusion criteria
  • Are unable or unwilling to be examined
  • Adults unable to provide their own consent
  • Have active, on-going medical problems such as (e.g. diabetes, hypothyroidism, pancreatitis, anemia, cancer, renal, hepatic, pulmonary or cardiac disease) or who have undergone recent surgery (i.e. less than 8 days post-surgery)
  • Pregnant females
  • Currently taking any or a combination of anti-inflammatory drugs, statins or other drugs with known myotoxicity, narcotics

Exclusion

    Key Trial Info

    Start Date :

    November 3 2014

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    Estimated Enrollment :

    11 Patients enrolled

    Trial Details

    Trial ID

    NCT01851447

    Start Date

    November 3 2014

    Last Update

    December 31 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892

    Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy | DecenTrialz